CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: 68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
Summary
A clinical trial is recruiting to evaluate 68Ga-NK224 PET imaging for PD-L1 expression across cancers.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Tumor, PD-L1 | Status: RECRUITING